Global Shortage of GLP-1 Agonists Prompts FDA to Authorize Compounding Pharmacies for Tiered Dosing
The FDA has authorized compounding pharmacies to prepare customized, tiered-dose formulations of GLP-1 agonists to addre...
Read More →The FDA has authorized compounding pharmacies to prepare customized, tiered-dose formulations of GLP-1 agonists to addre...
Read More →Biogen and Eisai report Phase 3 success for NeuroClear, a bispecific antibody that crosses the blood-brain barrier via t...
Read More →CMS has finalized a mandate requiring Medicare payers to use AI-driven, FHIR-based interoperability for prior authorizat...
Read More →The WHO has declared the end of the Mpox PHEIC following the 98.2% efficacy of the novel NX-2120 mRNA vaccine. The singl...
Read More →The FDA has approved Panca-Cel, the first universal allogeneic CAR-T cell therapy for refractory pancreatic cancer. Engi...
Read More →